HomeClinical TopicsFDA approves new drug for eczema
Clinical TopicsDrugs and DevicesNewsWeb Exclusives

FDA approves new drug for eczema

On March 28, the U.S. Food and Drug Administration (FDA) approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema. Read more

Previous articleThe unbeaten path leads to a growing nursing career
Next articleFDA approves maintenance treatment for patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Couple talking to NP

Getting Covid Vaccine Won’t Hurt Pregnancy Chances; Getting Covid Could

Couples planning a pregnancy might be relieved to know that getting a Covid vaccine does not hurt their odds of conceiving, according to the...

Powered by  HCM   www.HealthComMedia.com

© 2022 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.